NDC 50102-120-01 - AUBRA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50102-120
- Requested NDC
- 50102-120-01
- Package NDCs from labels
- 50102-120-00, 50102-120-01, 50102-120-48, 50102-120-10, 50102-120-03
- Manufacturer
- Afaxys Pharma, LLC | Mylan Laboratories Limited
- Effective date
- 2021-01-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AUBRA - Afaxys Pharma, LLC | Mylan Laboratories Limited | Afaxys Pharma, LLC | Mylan Laboratories Limited | 2021-01-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) | RPK Pharmaceuticals, Inc. | 2020-12-15 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50102-120-03 | 2023-02-17 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
| 50102-120-48 | 2023-02-17 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
| 50102-120-03 | 2023-01-30 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
| 50102-120-48 | 2023-01-30 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50102-120-00 | EA - Each | 50102-120 | d9bee6d9-aa9d-4898-93de-438dae2bb869 | 1 | 2022-06-06 |
| 50102-120-01 | EA - Each | 50102-120 | 8b796782-496f-4ed0-b025-66127b0fc3f9 | 1 | 2013-11-04 |
| 50102-120-03 | EA - Each | 50102-120 | c2265cdf-ed8f-437d-9e4b-312af0119f71 | 1 | 2017-09-11 |
| 50102-120-10 | EA - Each | 50102-120 | 5c1fb698-e254-4b92-8ed9-eb87d3604632 | 1 | 2017-09-11 |
| 50102-120-48 | EA - Each | 50102-120 | 8a66d499-33ea-4443-a859-d114a3240255 | 1 | 2013-11-04 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LEADER Emergency Contraceptive Levonorgestrel | LEVONORGESTREL | Cardinal Health 110, LLC. DBA Leader | d1e33615-0a98-4223-833d-843c758d9db7 | 2026-05-06 | Warnings | 5W7SIA7YZW |
| Calamine | FERRIC OXIDE RED | Retail Business Services, LLC | 7291e175-a9b6-4c47-93ce-227ce11e4599 | 2026-04-30 | Warnings, Adverse reactions | 1K09F3G675 |
| My Choice | LEVONORGESTREL | OHM LABORATORIES INC | 500d9418-69a8-f4f3-e063-6394a90a9b66 | 2026-04-22 | Warnings | 5W7SIA7YZW |
| norelgestromin and ethinyl estradiol | NORELGESTROMIN AND ETHINYL ESTRADIOL | Zydus Pharmaceuticals USA Inc. | 10fa1458-c8ed-4197-922a-1ba7271d2b02 | 2026-04-16 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| norelgestromin and ethinyl estradiol | NORELGESTROMIN AND ETHINYL ESTRADIOL | Zydus Lifesciences Limited | 7c2cc8ab-db6d-4a1c-ae74-e0ef27e2f3a9 | 2026-04-16 | 423D2T571U | |
| Calamine | CALAMINE 8%, ZINC OXIDE 8% | Farmacias De Similares TX LLC | 4ecd0add-11c9-cf3b-e063-6394a90adff6 | 2026-04-06 | Warnings | 1K09F3G675 |
| Norethindrone Acetate and Ethinyl Estradiol | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 38924c83-53aa-4279-8f0e-1a5d8f5fd8ad | 2026-03-26 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Climara Pro | ESTRADIOL AND LEVONORGESTREL | Bayer HealthCare Pharmaceuticals Inc. | 184d3092-7fc6-4375-816b-1ab06bb99cfd | 2026-03-26 | Boxed warning, Warnings, Adverse reactions | 5W7SIA7YZW |
| LEVONORGESTREL | LEVONORGESTREL | Camber Consumer Care Inc | 2e22d0c4-b308-4a02-b2b0-2c06fb91d1e5 | 2026-03-23 | Warnings | 5W7SIA7YZW |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 4d3a0a92-b0de-a1ea-e063-6294a90a8508 | 2026-03-17 | Warnings | 1K09F3G675 |
| Junel FE | JUNEL FE | Direct_Rx | ea62a66e-d45d-11be-e053-2a95a90a7801 | 2026-03-17 | Warnings, Adverse reactions | 423D2T571U |
| Skyla | LEVONORGESTREL | Bayer HealthCare Pharmaceuticals Inc. | 9f44ff35-e052-49cd-a1c2-0bfd87d49309 | 2026-03-04 | Warnings, Adverse reactions | 5W7SIA7YZW |
| Calamine | CALAMINE, PRAMOXINE HCL | Amazon.com Services LLC | aceb0b10-8c90-4a06-8c47-cd1a2b4676a3 | 2026-03-03 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | Old East Main Co. | c38c77fd-abbf-4c87-a9c0-a0e21ed3f97d | 2026-03-02 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | Chain Drug Marketing Association | 86ff4875-9007-4b7b-8f46-16cbd475d4bb | 2026-02-27 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXINE HCL | Chain Drug Marketing Association | 6c848b98-f01c-40f2-a9aa-2af76cb370c8 | 2026-02-27 | Warnings, Adverse reactions | 1K09F3G675 |
| Levico Prunus | LEVICO PRUNUS | Uriel Pharmacy Inc. | 63db9374-8ee2-48cf-8799-454c95869808 | 2026-02-27 | Warnings | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | Family Dollar Stores, Inc | 1a03331e-3676-451c-be22-9a547e8ae6e2 | 2026-02-24 | Warnings, Adverse reactions | 1K09F3G675 |
| Restart | LEVONORGESTREL | Winx Health Inc. | 0cdf198e-c114-b9fa-e063-6294a90a566a | 2026-02-24 | Warnings | 5W7SIA7YZW |
| Calamine | FERRIC OXIDE RED | Perrigo Direct, Inc | 256bd1d4-fd50-408f-9aee-84f218bb4971 | 2026-02-19 | Warnings, Adverse reactions | 1K09F3G675 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.